Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between the ages of 30 and 64 years old.
- Women experiencing symptoms such as unusual white discharge, bleeding after sex, or bleeding between periods.
- Women whose cervix has been noted by a doctor to appear unhealthy, such as showing signs of erosion, bleeding when touched, or unusual surface changes.
- Women whose Pap smear (cervical screening test) results have shown abnormal cell changes.
Who may not be able to join:
- Women who are currently pregnant.
- Women who are currently experiencing active vaginal bleeding.
- Women who have previously had any treatment for abnormal cervical cells or lesions.
- Women who have a visible abnormal growth on the cervix (confirm with trial site).
- Women who have had a hysterectomy (surgical removal of the uterus).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hazem A prof, MD, Sohag university hospitals
Phone: +201022827251
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
comparison between colposcopic findings of suspicious cervix and histopathologic findings
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.